|Publication number||US3925164 A|
|Publication date||Dec 9, 1975|
|Filing date||Mar 25, 1974|
|Priority date||Mar 28, 1973|
|Also published as||CA1067804A, CA1067804A1, DE2315501A1, DE2315501B2, DE2315501C3, DE2316637A1|
|Publication number||US 3925164 A, US 3925164A, US-A-3925164, US3925164 A, US3925164A|
|Inventors||Klaus Beaucamp, Hans Mollering, Gunter Lang, Wolfgang Gruber, Peter Roeschlau|
|Original Assignee||Boehringer Mannheim Gmbh|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (2), Referenced by (39), Classifications (28)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent I191 Beaucamp et al. Dec. 9, 1975  METHOD F R THE DETERMINATION OF 3,776,816 l2/l973 Terada et al 195/1015 R CHOLESTEROL FOREIGN PATENTS 0R APPLICATIONS  inventors: Klaus Beaucamp; Hans Miillering; 2'246695 3/1973 Germany Gunter Lang; Wolfgang Gruber; Peter Roeschlau, all of Tutzing, Upper Bavaria, Germany Boehringer Mannheim GmbH, Mannheim-Waldhof, Germany Filed: Mar. 25, 1974 Appl. No.: 454,522
UNITED STATES PATENTS 9/l97l Stone l95/l03.5 R
OTHER PUBLICATIONS J. Hyun et al., The .l. of Biol. Chem.," 244, No. 7, pp. 19374945, 1969.
Primary Examiner-A. Louis Monacell Assistant ExaminerC. A. Fan
Attorney, Agent, or Firm-Burgess, Dinklage & Sprung  ABSTRACT Total cholesterol or bound cholesterol in a sample is determined by treating the sample with cholesterol esterase, thereby releasing the bound cholesterol, and then determining the resulting total cholesterol by known methods; specifically preferred are cholesterol esterases from Candida rugosa ATCC 14830, Rhizopus spec. WS 90027 and Aspergillus spec. WS 90030.
18 Claims, No Drawings METHOD FOR THE DETERMINATION OF CHOLESTEROL The present invention relates to a method of determining cholesterol, and more specifically to a method of determining either total cholesterol or bound cholesterol.
Cholesterol is present in biological matter, such as serum or the like, partially in free form and partially in bound form as ester. For the determination of either bound cholesterol or total cholesterol it is necessary first to release the cholesterol that is present in bound form. This has been done hitherto through saponification under alkaline conditions, using alcoholic potash lye, for example. After the saponification, the released cholesterol can then be determined either chemically or enzymatically by one of the known methods. The chemical determination may be performed, for example, by the Lieberrnann-Burchard method, and enzymatic determination may be performed by means of cholesterol oxidase, cholesterol dehydrogenase or cholesterol dehydrase. Since the individual cholesterol esters as well as the free cholesterol are known to have different extinction coefficients in the chemical methods of determination, it is necessary to transform the cholesterol esters to free cholesterol by alkaline hydrolysis.
In any case, however, the alkaline saponification of the bound cholesterol is a troublesome and time-consuming step in the procedure. Furthermore, the relatively agressive reagents used may lead to a decomposition of the cholesterol. In order to prevent such decomposition and thus forestall falsification of the results of the analysis, a hydrolysis must be performed under relatively mild conditions, and this in turn undesirably increases the length of time required for the determination.
The alkaline liberation of the cholesterol is especially disadvantageous when the determination of the cholesterol is afterwards to be performed by the preferred enzymatic methods. Since the enzymes are inactivated, as it is known, in the strongly alkaline medium, the hydrolyzate must be acidified by the addition of acid to pH 5 to 8 before the enzymatic determination can be started. All this results in the fact that the determination of the total cholesterol or of the bound cholesterol still takes an undesirably long time and requires too much work.
The present invention provides a process for the determination of total cholesterol or bound cholesterol which substantially obviates the above-mentioned disadvantages.
Essentially, the process of the invention comprises the determination of total cholesterol or of bound cholesterol by releasing the bound cholesterol using cholesterol esterase, followed by determination of the released cholesterol by known methods.
It has been found that, using cholesterol esterase, a rapid and quantitative saponification of bound cholesterol can be performed. This process is especially advantageous whenever the subsequent determination of the released cholesterol is performed enzymatically, using cholesterol oxidase or cholesterol dehydrase, for example. In this case, the process of the invention makes possible the all-enzymatic determination of cholesterol and therefore a decided improvement of routine medical diagnosis plus an easy adaptation of the process for performance in automatic analysis apparatus.
It is already known that in the pancreas and liver a cholesterol esterase is present. It could not be concluded from this knowledge, however, that such an enzyme would be suitable for the rapid, complete saponification of cholesterol esters in the framework of a quantitative analysis process, because the cleavage rates determined were not quantitative, amounting to only maximum (Biochimica et Biophysica Acta 270, (1972), 156-166). Furthermore, bound cholesterol is present in biological matter in the form of esters of widely different acid. For an enzymatic process to be useful in the framework of a process of analysis, it is required that all of the esters that may occur be cleaved quantitatively with approximately the same speed and with the same reliability. On account of the known properties of these enzymes it is surprising that the cholesterol esterases are capable of cleaving quantitatively, within a very short time, all of the cholesterol esters that occur. This is especially surprising also because in the known cholesterol esterases there are considerable differences with regard to their activity against various cholesterol esters.
Cholesterol esterases from microorganisms have proven to be especially suited for the process of the invention. They have proven superior to cholesterol esterases of other origin in regard to speed of cleavage and effectiveness and they are therefore preferred within the scope of the invention.
it has also been found that a number of microorganisms contain particularly active cholesterol esterases and can therefore be used directly within the scope of the invention without separation and purification of the cholesterol esterases. This is advantageous in avoiding the separation of certain esterases from the normally used mixture of a plurality of cholesterol esterases specific for various cholesterol esters. Such separation would greatly complicate the quantitative determination of all of the bound cholesterol.
In addition, the purification of the bound cholesterol esterases in lipoid membranes is difficult, and therefore results in a preparation which is less suitable, on account of its price, for use in routine diagnosis than a microorganism preparation which can be used without any enzyme purification.
Particularly advantageous results have been obtained in the process of the invention by the use of a cholesterol esterase derived from Candida rugosa (also referred to as Cylindracea) ATCC 14830 and WS 90031, respectively, and from Aspergillus spec. WS 90030. These two microorganisms may be used directly as such or in processed form, e.g., in the form of an acetone dry powder, within the scope of the invention. It is also, of course, possible to use a concentrated cholesterol esterase preparation made from these microorganisms, there being a special advantage in the fact that a certain concentration may in this case be achieved very simply. Candida rugosa is a microorganism that is produced on a large technical scale and is available commercially. The customary commercial form is an acetone dry powder stabilized with lactose, which has proven to be outstandingly suited for the invention. Similarly attractive properties have been found in:
Actinom yces aureoverticillium WS 90002 Acn'nam yces cyaneofurcatus WS 90003 Acu'nomyces griseomycini WS 90004 Am'nomyces longisparus-fl. WS 90005 Acn'nomyces malachiticu: WS 90006 Acrinom yces roseolus WS 90007 -contmued Actinomyces toxym'cini WS 90008 Aclinomyces variabih's WS 90009 Srrepwmyces .rpec. WS 90010 Srreplomyces autotrophicus WS 9001 l Streptomyccs canes-certs WS 90012 Streptomyces charlreusis WS 90013 Streptomyces michiganensis WS 90014 Streptomyces murinu: WS 90015 Streptomyces hachijoensis WS 90016 Streptomyces caelestes WS 90017 Streptomyces tendae WS 900l8 Nocardia rubra WS 90019 Candida m ycoderma WS 90020 Candida albicans WS 9002] Candida albicans WS 90022 Candida albicans WS 90023 Candida spec. WS 90024 Cunninghamella elegans WS 90025 Mucar mucedo WS 90026 Rhizopus spec. WS 90027 Penicillium spec. WS 9002B Aspergillus spec. WS 90029 In addition to the preferred cholesterol esterases of microbiological origin, however, cholesterol esterases of other origin may also be used in many cases.
As previously mentioned, an especially important advantage of the process of the invention consists in the fact that it makes possible an all-enzymatic determination of total cholesterol. it is important in this case that, with the preferred cholesterol esterase preparations made from microorganisms; a rapid and quantitative release of the cholesterol from its esters is possible. Especially with the preferred microorganisms mentioned above, it is possible by the direct addition of same in a very small quantity, with the maintenance of the pH values and temperatures which are desirable in the subsequent enzymatic determination of cholesterol, to achieve within a few minutes a quantitative release of the cholesterol, it having been found that the common carbohydrate-based stabilizing agents which are used for such microorganisms do not interfere with the cholesterol determination performed within the framework of the allenzymatic process.
As mentioned, a separated and concentrated cholesterol esterase, preferably one obtained from microorganism, may also be used for the process of the invention. A suitable concentration may be achieved by setting out from an acetone dry powder of the microorganism or other biological material and subjecting it to a dialysis, a treatment with weakly basic anion exchanger and to an ammonium sulfate fractionation. In this manner, it is easy to achieve a -fold to 30-fold concentration of the cholesterol esterase. A preparation on a carbohydrate basis, modified with diethylaminoethanol groups, has proven to be an especially suitable weakly basic anion exchanger. In the ammonium sulfate fractionation, the fraction between 1.8 and 2.4 moles of ammonium sulfate is preferably obtained. The enzyme fraction thus obtained is then chromatographed, preferably on the above-named exchanger material.
Particularly good results are obtained within the scope of the invention with microorganisms which have been cultivated in a nutrient medium containing cholesterol ester. In this case, the cholesterol ester or a mixture of cholesterol esters may be added during the cultivation as the sole source of carbon, or may be used together with another carbon source. Especially preferred is the use of microorganisms which are obtained in a multi-stage cultivating process, in which they are cultivated in the first stage on a suitable carbon supplier, such as glycerin, and in the second stage on a cholesterol ester. A suitable cultivation process is described, for example, in German Published Specifications (Offenlegungsschriften") Nos. 2,224,133 and 2,307,518.
The cholesterol esterase from Candida rugosa ATCC l4830 used preferentially in accordance with the invention has very good stability in the weakly acid region between pH 5 and 6.5. The optimum pH for the enzyme is 7.5. One peculiarity of the enzymes is that the catalytic reaction takes place especially well when the salt content of the reaction medium is relatively high. Preferably, therefore, the process is performed in an 0.2 to 0.8 molar buffer solution. The pH may range between 4.5 and 7.5, and will preferably range, as stated above, between pH 5 and 6.5. The effectiveness of the cholesterol esterase is preferably increased by the addition of surface active substances. Especially preferred is the addition of hydroxypolyethoxydodecane.
As previously mentioned, it is especially preferred that the process of the invention be performed allenzymatically, i.e., the cholesterol determination that follows is also performed enzymatically, preferably with the use of cholesterol oxidase. However, cholesterol dehydrase or dehydrogenase may also be used.
Determination with cholesterol oxidase is described, for example, in German Offenlegungsschrift No. 2,224,132. The process therein described may advantageously be combined with the process of the invention. In this case, it is possible in principle to measure the oxygen consumption, the H 0, formation or the formation of cholestenone. The determination of the oxygen consumption may be performed, for example, by gas chromatography or polarometry, or by the polarization method. These methods of determination are in the prior art. The hydrogen peroxide that forms may be determined titrimetrically, potentiometrically, and colorimetrically, as well as enzymatically. Enzymatic determination is preferred, with the use of catalase or peroxidase, especially determination by catalase in the presence of beta diketones such as acetylacetone, low alcohols and buffer containing ammonium ions, or determination by peroxidase in the presence of a chromogen such as 2,2-aminobenzothiazolinesulfonic acid. Cholestenone is determined by means of keto reagents such as 2,4-dinitrophenylhydrazine, or by photometry at 240 lf the all-enzymatic determination of the total or bound cholesterol is performed with cholesterol oxidase, a cholesterol oxidase obtained from Nocardia erylhropolis ATCC l7895, Nocardia erythropolis ATCC 4277, Nocardia formica ATCC l48ll or Proacu'nomyces eryzhropolis NClB 9158 is preferably used.
Additional subject matter of the invention is a reagent for the determination of cholesterol which consists of cholesterol esterase and a reagent for the determination of free cholesterol. Preferably, a reagent of this sort consists of a cholesterol esterase of microbiological origin, cholesterol, oxidase, a system for the determination of hydrogen peroxide, or a system for the determination of cholestenone. Quite especially preferred in this case is a reagent in which the cholesterol esterase is one of the microorganisms mentioned further above, especially in the form of an acetone dry powder or a protein fraction obtained therefrom having cholesterol esterase activity.
[n a special and preferred embodiment, such a reagent consists of cholesterol oxidase, a cholesterol esterase preparation made from one of the above-mew tioned microorganisms, catalase, acetyl acetone, methanol and aluminum ion-containing buffer, individually or mixed. In still another preferred embodiment, the reagent consists of cholesterol oxidase, a preparation made of the above-mentioned microorganisms having cholesterol esterase activity, peroxidase, chromogen and buffer, individually or mixed. 2,2'-aminobenzothiazolinesulfonic acid is preferred as the chromogen.
In still another preferred embodiment, the reagent of the invention consists of cholesterol oxidase, a cholesterol esterase preparation made from one of the named microorganisms, and a hydrazine derivative reacting with keto groups with the formation of hydrazone, and in some cases a buffer. 2,4-dinitrophenylhydrazine is preferred as the hydrazine derivative.
The above-mentioned preferred reagent combinations may contain, in addition to the specified essential components, commonly used solvents, stabilizers and- /or suface active substances. All these additive substances are known to persons skilled in the art and commonly used in detection systems for hydrogen peroxide and cholestenone.
Preferably, the above-mentioned reagent combinations will contain the essential components in the following rations:
l. 13 to 150 U of cholesterol oxidase, 0.05 to 0.5 mg
of microorganism cholesterol esterase, 2 X to 5 X 10 units of catalase, 0.05 to 0.2 ml of acetyl acetone and 2 to 10 ml of methanol in 100 ml of a pH 5 to 7 buffer containing ammonium ions, plus, if desired, 0.02 to 0.3 ml of a surface active agent, preferably hydroxypolyethoxydodecane.
2. 3 to 40 U of cholesterol oxidase, 0.05 to 0.5 mg of microorganism cholesterol esterase, and 2 X 2 to l X 10 U of peroxidase, 50 to 200 mg. of 2,2'amino-benzothiasolinesulfonic acid, and, if desired, 0.05 to 0.5 ml of surface active agent, preferably hydroxypolyethoxydodecane, in lOO ml of pH 6 to 8 buffer.
3. 0.l to l U ofcholesterol oxidase, 0.05 to 0.5 mg of microorganism cholesterol esterase, l to 5 ml of a 1 mM solution of 2,4-dinitrophenylhydrazine, and, if desired, 0.005 to 0.1 ml of surface active agent in 10 ml of pH 6 to 8 buffer.
4. 2 to I00 U of cholesterol oxidase, 0.05 to 0.5 mg
of microorganism cholesterol esterase, and, if desired, 0.1 to 2.0 ml of surface active agent (preferably hydroxypolethoxydodecane), in 50 ml of pH 5 to 9 buffer, preferably 0.5 m of sodium phosphate pH 7.5 buffer.
With the process and reagent of the invention, an extremely rapid and complete saponification of bound cholesterol determination with cholesterol oxidase in accordance with the invention, a quantitative cleavage of bound cholesterol is accomplished within one to three minutes with the addition of Candida rugosa ATCC 14830 or Aspergillus sp. WS 90030 acetone dry powder in a quantity between 0.1 to 0.3 mg. The following examples are illustrative.
EXAMPLE 1 Using the method described in Example 1 of German Offenlegungsschrift No. 2,224,l32, the content of free cholesterol in serum was found to be 63 mg% (63 mg in 100 ml). For the determination of bound cholesterol, a
6 specimen of the same serum was treated for 30 minutes with alcoholic potash lye at C. After neutralization and measurement of the cholesterol present, a total content of 181 mg% of cholesterol was found. From this appears that l 18 mg of cholesterol were present in bound form for every I00 ml.
The process was repeated with untreated serum, but at the beginning of the determination 0.3 mg% (with reference to the protein) of an acetone dry powder of Candida rugosa ATCC 14830 in commercial form was added. After 3 minutes, polarographic determination showed a content of 183 mg% total cholesterol.
EXAMPLE 2 To concentrate the cholesterol esterase activity, commercial acetone dry powder of Candida rugosa ATCC l4830 was dissolved in potassium phosphate buffer pH 6.0 and dialyzed against the same buffer. After removal of the lactose contained in the solution as stabilizer, the specific cholesterol esterase activity was 0.3 U per mg of protein in the dialyzed solution.
The solution thus obtained was stirred together with an ion exchanger on a dextran basis modified with diethylaminoethanol groups; the exchanger was separated and eluted with 0.2 M of pH 6.0 phosphate buffer. A specific cholesterol esterase activity of L2 U/mg was found in the eluate.
The solution thus obtained was subjected to an ammonium sulfate fractionation. The protein fraction that precipitated between 1.8 and 2.4 M of ammonium sulfate was separated, and had a specific cholesterol esterase activity of 2.5 U/mg.
The product obtained was again dissolved in pH 6.0 phosphate buffer, dialyzed against the same buffer until salt-free, and then chromatographed on a column filled with the same anion exchanger as above. Elution was again performed with 0.2 M of pH 6.0 phosphate buffer. A specific activity of 7 U per mg of protein was found in the fraction having cholesterol esterase activity.
The concentrated cholesterol esterase preparation thus obtained was used in the cholesterol determination as described in Example 1, except that the amount used was only 0.001 mg with reference to protein. The results were the same as in Example 1.
The cholesterol esterase from Candida rugosa can be further purified by the conventional methods of enzyme refinement. Instead of the concentration procedures cited above, other conventional biochemical refinement procedures may be used, such as precipitation or fractionation with polyethyleneimine, organic solvents or salts, by chromatography through molecular sieve materials or weak anion exchanger with functional groups other than diethylaminoethanol groups. by protamine sulfate precipitation and the like.
EXAMPLE 3 To 0.5 ml of serum in the one case and cholesterol standard in the other, I .0 ml of 0.5 M potassium phosphate pH 7.5 buffer containing 0.4% hydroxypolethoxydodecane, and 2.5 U of cholesterol esterase from Example 2 were added. This reaction mixture was incubated for 40 minutes at 37C. Then 0.25 ml of this solution was added to 3 ml of cholesterol reagent containing two parts acetic acid, three parts acetic acid anhydride and one part sulfuric acid (Liebermann-Burchardt reagent).
By using a standard as a reference magnitude, 170 mg% total cholesterol was found in a typical specimen. Comparative determination after saponification of the cholesterol ester with alcoholic potash lye gave 165 mg%.
EXAMPLE 4 l ml of 0.5 M potassium phosphate buffer containing 0.4% hydroxypolyethoxydodecane, and 0.2 U of the cholesterol esterase of Example 2, were added to 0.02 ml of serum. The reaction solution was incubated for 60 minutes 37C. Then the extinction (E at 240 nm was read in a suitable spectral photometer and the reaction was started with 0.1 U of sterol dehydrase obtained from Brevibaclerium sterolicum. After fifteen minutes, the extinction (E was again read. The concentration of the A cholestenone and hence of the cholesterol was found from the difference between the first and second reading on the basis of the molar extinction coefficient for A cholestenone at 240 nm. Measurement of a typical specimen gave 183 mg% total cholesterol.
Comparative determination with a cholesterol oxidase from Nocardia erythropolis instead of sterol dehydrase gave I81 mg% cholesterol.
EXAMPLE 5 g of diammonium hydrogen phosphate was dissolved in 100 ml of water and adjusted to pH 7.0 with 85% phosphoric acid. Then 10 units of catalase were added. The solution thus obtained was added to a mixture of 0.2 ml of acetyl acetone, l0 ml of methanol and 0.1 g of hydroxypolyethoxydodecane to produce a volume of 100 ml. To this solution, 2.5 units of cholesterol esterase from Rhizopus spec. (WS 90027) were added. 5.0 ml of the solution thus obtained was mixed with 0.02 ml of serum in the one case and 0.02 ml of a cholesterol standard solution containing 200 mg% cholesterol in the other. To aliquots of the serum-containing specimen and of the cholesterol standard-containing specimen 0.1 unit of cholesterol oxidase was added and the mixtures were incubated for 60 minutes at 37C. Then the dye that was formed was measured photometrically at 405 nm on the basis of the specimen zero value.
Using a standard as a reference magnitude, the cholesterol content of the serumcontaining specimen amounted to l54 mg% total cholesterol. The control determination performed with cholesterol esterase from Candida rugosa ATCC 14830 instead of cholesterol esterase from Rhizopus spec. (WS 90027) gave the same value.
It will be understood that the specification and examples are illustrative but not limitative of the present invention and that other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.
What is claimed is:
1. Method of determining total cholesterol or bound cholesterol in a sample, which method comprises treating said sample with cholesterol esterase obtained from a micro-organism, thereby releasing the bound cholesterol, and then determining the resulting cholesterol content of said sample using a standard determinatiion.
2. Method as claimed in claim 1 wherein said sample contains only bound cholesterol and the said determination determines the amount of said bound cholesterol.
3. Method as claimed in claim 1 wherein said sample contains free cholesterol and bound cholesterol and the said determination determines total cholesterol.
4. Method as claimed in claim 1 wherein said microorganism is Candida rugosa ATCC M830.
5. Method as claimed in claim 1 wherein said micro organism is Rhizopus spec. WS 90027.
6. Method as claimed in claim 1 wherein said microorganism is Aspergillus spec. WS 90030.
7. Method as claimed in claim 1 wherein said microorganism is Acrirmmyces aureovern'cillium WS 90002 Aclinamyces cyaneofuscatus WS 90003 Aclinamyces griseomycini WS 90004 Actinomyces longispurus-fl. WS 90005 Aclinomyces malachr'rr'cu: WS 90006 Acn'namyces mseolus WS 90007 Acn'nomyces mxym'cr'ni WS 90008 Acn'nomyces variabilis WS 90009 Slreplomyces spec. WS 900l0 Srrepmmytes aulotrophicus WS 900] l Srrepmmyces canescens WS 900 l 2 Srrepmmyces charrreusl's IS 90013 Strepromyces michiganensl's WS 900M Streptomyces murinus WS 900|5 Streptomyces hachljoensis WS 90016 Strepwmyces caelestis \VS 900l 7 Strepwmyces lendae WS 900l 8 Nocardr'a rubra WS 90019 Candida mycoderma WS 90020 Candida albl'cans WS 9002l Candida albicans WS 90022 Candida albicans WS 90023 Candida spec. WS 90024 Cunninghamella elegans WS 90025 Mucor mucedo WS 90026 Penicillium spec. WS 90028 or Aspergillus spec. WS 90029.
8. Method as claimed in claim 1 wherein said determination is an enzymatic determination.
9. Method as claimed in claim 8 wherein the enzyme used for said enzymatic determination is cholesterol oxidase.
10. Method as claimed in claim 9 wherein said cholesterol oxidase is from Nocardia erythropolis ATCC 17895, Nocardia eryth ropolis ATCC 4277, Nocardia formica l48l l or Proactinomyces erythropolis NClB 11. Method as claimed in claim 1 wherein said microorganism has been cultivated on a cholesterol ester containing nutrient medium.
12. Reagent composition for the determination of cholesterol in a sample, with composition comprises cholesterol esterase obtained from a microorganism and a system for the determination of free cholesterol.
l3. Reagent composition as claimed in claim 12 wherein said composition comprises a cholesterol esterase from a microorganism,
a system for the determination of hydrogen peroxide.
14. Reagent composition as claimed in claim 13 wherein said microorganism is Candida rugoas ATCC 14830, Rhizopus spec. WS 90027 or Aspergillus spec. WS 90030.
15. Reagent composition as claimed in claim 12 comprising cholesterol esterase,
and a buffer containing ammonium ions.
9 16. Reagent composition as claimed in .claim 14 containing peroxidase, a chromogen, a buffer,
a system for the determination of H Oh 17. Reagent composition as claimed in claim 12 wherein said composition comprises groups, to result in the formation of hydrazone.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3607093 *||Feb 15, 1968||Sep 21, 1971||Schering Corp||Devices for testing biological liquids|
|US3776816 *||Aug 21, 1972||Dec 4, 1973||Kyowa Hakko Kogyo Kk||Process for producing steroid dehydrogenase|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4184921 *||Apr 28, 1978||Jan 22, 1980||Boehringer Mannheim Gmbh||Process and reagent for determining cholesterol|
|US4259440 *||May 21, 1979||Mar 31, 1981||Miles Laboratories, Inc.||Hydrolysis and assay of triglycerides|
|US4275151 *||Dec 18, 1978||Jun 23, 1981||Eastman Kodak Company||Hydrolysis of protein-bound cholesterol esters|
|US4275152 *||Jul 30, 1979||Jun 23, 1981||Eastman Kodak Company||Hydrolysis of protein-bound cholesterol esters|
|US4343903 *||Aug 6, 1980||Aug 10, 1982||Boehringer Mannheim Gmbh||Process for obtaining cholesterol esterase from micro-organisms|
|US4360596 *||Aug 6, 1980||Nov 23, 1982||Boehringer Mannheim Gmbh||Process for the preparation of cholesterol esterase|
|US4378429 *||Aug 21, 1981||Mar 29, 1983||Modrovich Ivan Endre||Enzymatic method and stabilized solutions for determining total cholesterol in human serum|
|US4387163 *||Jul 13, 1981||Jun 7, 1983||E.N.I. Ente Nazionale Idrocarburi||Process for producing the enzyme cholesterol esterase and for hydrolyzing cholesterol esters of fatty acids by using the enzyme itself|
|US5110724 *||Apr 2, 1990||May 5, 1992||Cholestech Corporation||Multi-analyte assay device|
|US5114350 *||Mar 8, 1989||May 19, 1992||Cholestech Corporation||Controlled-volume assay apparatus|
|US5156954 *||Mar 8, 1989||Oct 20, 1992||Cholestech Corporation||Assay device and method using a signal-modulating compound|
|US5171688 *||Aug 23, 1989||Dec 15, 1992||Cholestech Corporation||Self-corrected assay device|
|US5340539 *||Oct 8, 1992||Aug 23, 1994||Chemtrak, Inc.||Non-instrumented cholesterol assay|
|US5350675 *||Sep 8, 1992||Sep 27, 1994||Fuji Photo Film Co., Ltd.||Multilayer analytical element for determination of total cholesterol in blood|
|US5445769 *||Jun 27, 1994||Aug 29, 1995||Fuisz Technologies Ltd.||Spinner head for flash flow processing|
|US5456932 *||Apr 22, 1994||Oct 10, 1995||Fuisz Technologies Ltd.||Method of converting a feedstock to a shearform product and product thereof|
|US5503862 *||May 26, 1995||Apr 2, 1996||Fuisz Technologies Ltd.||Method of subjecting a protein-containing material to flash flow processing and product thereof|
|US5520859 *||Apr 8, 1994||May 28, 1996||Fuisz Technologies Ltd.||Method for flash flow processing having feed rate control|
|US5549917 *||Jun 7, 1995||Aug 27, 1996||Fuisz Technologies Ltd.||Flash flow formed solloid delivery systems|
|US5556652 *||Aug 5, 1994||Sep 17, 1996||Fuisz Technologies Ltd.||Comestibles containing stabilized highly odorous flavor component delivery systems|
|US5576042 *||Mar 2, 1994||Nov 19, 1996||Fuisz Technologies Ltd.||High intensity particulate polysaccharide based liquids|
|US5582855 *||Jul 1, 1994||Dec 10, 1996||Fuisz Technologies Ltd.||Flash flow formed solloid delivery systems|
|US5587198 *||May 31, 1995||Dec 24, 1996||Fuisz Technologies Ltd.||Positive hydration method of preparing confectionery and product therefrom|
|US5597608 *||Dec 28, 1994||Jan 28, 1997||Fuisz Technologies Ltd.||Saccharide-based matrix incorporating maltodextrin and process for making|
|US5610025 *||Jul 16, 1993||Mar 11, 1997||Actimed Laboratories, Inc.||Inhibition of interfering endogenous enzyme activity in assays of biological fluids|
|US5624684 *||May 13, 1992||Apr 29, 1997||Fuisz Technologies Ltd.||Enzyme systems|
|US5633027 *||Jun 7, 1995||May 27, 1997||Fuisz Technologies Ltd.||Confectioneries containing stabilized highly odorous flavor component delivery systems|
|US5709876 *||Jun 7, 1995||Jan 20, 1998||Fuisz Technologies Ltd.||Saccharide-based matrix|
|US5744180 *||Oct 23, 1996||Apr 28, 1998||Fuisz Technologies Ltd.||Comestibles containing stabilized highly odorous flavor component delivery systems|
|US5804247 *||Dec 20, 1996||Sep 8, 1998||Fuisz Technologies Ltd.||Positive hydration method of preparing confectionary and product therefrom|
|US5824342 *||Apr 9, 1996||Oct 20, 1998||Fuisz Technologies Ltd.||Flash flow formed solloid delivery systems|
|US7795038||Apr 8, 2003||Sep 14, 2010||Cholestech Corporation||High-density lipoprotein assay device and method|
|US7824879||Jan 9, 2008||Nov 2, 2010||Cholestech Corporation||Device and method for measuring LDL-associated cholesterol|
|US20050074828 *||Jul 14, 2004||Apr 7, 2005||Dimagno Theodore John||Uae of lipase for high-density lipoprotein cholesterol detection|
|US20050214884 *||Nov 24, 2004||Sep 29, 2005||Sysmex Corporation||Method for stabilizing cholesterol dehydrogenase, cholesterol dehydrogenase-containing composition and cholesterol measuring reagent|
|US20080299543 *||May 29, 2008||Dec 4, 2008||Uti Limited Partnership||Method for Assessing Trace Element Related Disorders in Blood Plasma|
|EP0024578A1 *||Aug 1, 1980||Mar 11, 1981||Ivan Endre Modrovich||Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor|
|WO1989002925A1 *||Sep 20, 1988||Apr 6, 1989||Abbott Laboratories||Simultaneous assay for cholesterol and triglycerides|
|WO2015013515A2||Jul 24, 2014||Jan 29, 2015||Boston Heart Diagnostics Corporation||Driving patient compliance with therapy|
|U.S. Classification||435/11, 435/911, 435/27, 435/197, 435/28, 435/922, 435/19, 435/893, 435/933, 435/886, 435/827, 435/25, 435/921, 435/913|
|International Classification||C12Q1/60, C12N9/18|
|Cooperative Classification||Y10S435/827, Y10S435/921, Y10S435/922, Y10S435/913, Y10S435/933, Y10S435/893, Y10S435/911, C12N9/18, Y10S435/886, C12Q1/60|
|European Classification||C12N9/18, C12Q1/60|